Clinical Trial Update: Topical 5% Spironolactone Gel Versus 0.1% Adapalene Gel for Acne Vulgaris: A Randomized Split-Face Study [Phase 2]

View source ↗

Summary

A Phase 2 randomized split-face study compares topical 5% spironolactone gel with 0.1% adapalene gel for acne vulgaris; the trial status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• Adapalene gel (0.1%) (adapalene)
• Topical spironolactone gel (5%) (spironolactone)

Snippet

Sponsor: Assiut University | Conditions: Acne Vulgaris | Phase 2 | Status: NOT_YET_RECRUITING